Wang, Zeyang (2024): Evaluating the Impact of National Volume-Based Procurement: Evidence from China.
PDF
MPRA_paper_123015.pdf Download (2MB) |
Abstract
The Volume-Based Procurement (VBP) undertaken by governments significantly influences the healthcare landscape across numerous nations. Initiated in 2018 and broadened in 2019, the National Volume-Based Procurement in China has experienced eight phases of execution throughout key regions. This research utilizes a Difference-in-Differences (DID) framework to assess the effects of centralized procurement on pharmaceutical results. The results indicate that: (1) in the 2018 pilot phase, there was a significant reduction in drug expenditures, an increase in quantities, and a marked decline in prices; and (2) when analyzing the impact of all seven subsequent rounds, both expenditures and prices continued to show significant decreases, although quantities also saw a considerable decline.
Item Type: | MPRA Paper |
---|---|
Original Title: | Evaluating the Impact of National Volume-Based Procurement: Evidence from China |
Language: | English |
Keywords: | Volume-Based Procurement (VBP); Pharmaceutical Prices; Difference-in-Differences (DID) |
Subjects: | C - Mathematical and Quantitative Methods > C8 - Data Collection and Data Estimation Methodology ; Computer Programs H - Public Economics > H4 - Publicly Provided Goods > H40 - General I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health |
Item ID: | 123015 |
Depositing User: | Zeyang Wang |
Date Deposited: | 18 Dec 2024 10:47 |
Last Modified: | 18 Dec 2024 10:47 |
References: | Arrow, Kenneth J. 1965. “Uncertainty and the Welfare Economics of Medical Care: Reply (The Implications of Transaction Costs and Adjustment Lags).” The American Economic Review, 55(1/2): 154–158. Bandiera, Oriana, Andrea Prat, and Tommaso Valletti. 2009. “Active and Passive Waste in Government Spending: Evidence from a Policy Experiment.” American Economic Review, 99(4): 1278–1308. Biao, Wang, Zhang Tian-tian, Tang Xiao-yu, Jia Yun, and Luo Li. 2023. “A Study on the Sustainability of Price Reductions in National Volume-Based Drug Procurement Policy.” Chinese Journal of Health Policy, 16(4): 32–36. Callaway, Brantly, and Pedro H.C. Sant’Anna. 2021. “Difference-in-Differences with Multiple Time Periods.” Journal of Econometrics, 225(2): 200–230. Chen, Zui, Ze Song, and Chuanchuan Zhang. 2018. “The Policy Effects of Reforming the Separation of Drug Sales and Medical Services: An Empirical Analysis Based on Medical Insurance Reimbursement Data.” Journal of Financial Research, 460(10): 16–72. Cohen, Lauren, and Christopher J. Malloy. 2014. “Friends in High Places.” American Economic Journal: Economic Policy, 6(3): 63–91. Coviello, Decio, and Stefano Gagliarducci. 2017. “Tenure in Office and Public Procurement.” American Economic Journal: Economic Policy, 9(3): 59–105. E, Xie. 2009. “Inequality in Health and Healthcare Utilization Related to Income.” Economic Research Journal, (2): 92–105. Feldstein, Martin. 2017. “Underestimating the Real Growth of GDP, Personal Income, and Productivity.” Journal of Economic Perspectives, 31(2): 145–164. G., Hadley, and T.M. Whitin. 1963. Analysis of Inventory Systems. Englewood Cliffs, N.J.: Prentice Hall, Inc. Gongcheng, Zheng. 2003. “Social Security Reform and System Construction in China.” Journal of Renmin University of China, (1): 17–25. Heckman, James J., Hidehiko Ichimura, and Petra E. Todd. 1997. “Matching as an Econometric Evaluation Estimator: Evidence from Evaluating a Job Training Programme.” The Review of Economic Studies, 64(4): 605–654. Hengpeng, Zhu. 2007. “Deficiencies in the Medical System and Distortions in Drug Pricing.” Chinese Social Sciences, (4): 89–103, 206. Hohner, Gail, John Rich, Ed Ng, Grant Reid, Andrew J. Davenport, Jayant R. Kalagnanam, Ho Soo Lee, and Chae An. 2003. “Combinatorial and Quantity-Discount Procurement Auctions Benefit Mars, Incorporated and Its Suppliers.” Interfaces, 33(1): 23–35. Jacobson, Louis S., Robert J. LaLonde, and Daniel G. Sullivan. 1993. “Earnings Losses of Displaced Workers.” The American Economic Review, 685–709. Kang, Xiong, and Chen Hao. 2021. “Comparison of Centralized Drug Procurement Models of Non-State Organizations in China.” Healthy Development and Policy Research, 24(1): 20–23. Ke, Ginger Y., and James H. Bookbinder. 2012. “The Optimal Quantity Discount That a Supplier Should Offer.” Journal of the Operational Research Society, 63(3): 354–367. Li, Xiuhui, and Qinan Wang. 2007. “Coordination Mechanisms of Supply Chain Systems.” European Journal of Operational Research, 179(1): 1–16. Lorentzen, Peter. 2014. “China’s Strategic Censorship.” American Journal of Political Science, 58(2): 402–414. MacKay, Alexander. 2022. “Contract Duration and the Costs of Market Transactions.” American Economic Journal: Microeconomics, 14(3): 164–212. Martin K., Starr, and David W. Miller. 1962. Inventory Control: Theory and Practice. Englewood Cliffs, N.J.: Prentice Hall, Inc. Mironov, Maxim, and Ekaterina Zhuravskaya. 2016. “Corruption in Procurement and the Political Cycle in Tunneling: Evidence from Financial Transactions Data.” American Economic Journal: Economic Policy, 8(2): 287–321. Monahan, James P. 1984. “A Quantity Discount Pricing Model to Increase Vendor Profits.” Management Science, 30(6): 720–726. Peterson, Rein, and Edward Allen Silver. 1979. Decision Systems for Inventory Management and Production Planning. New York: John Wiley & Sons. Richard B., Chase, and Nicholas J. Aquilano. 1981. Production and Operations Management. Homewood, Ill.: Richard D. Irwin, Inc. Rosenbaum, Paul R., and Donald B. Rubin. 1983. “The Central Role of the Propensity Score in Observational Studies for Causal Effects.” Biometrika, 70(1): 41–55. Sethi, Suresh P. 1984. “A Quantity Discount Lot Size Model with Disposals.” International Journal of Production Research, 22(1): 31–39. Slavtchev, Viktor, and Simon Wiederhold. 2016. “Does the Technological Content of Government Demand Matter for Private R&D? Evidence from US States.” American Economic Journal: Macroeconomics, 8(2): 45–84. Wei, Wu, and Liu Yuting. 2020. “Government Procurement and Enterprise Innovation: Protective Effect and Spillover Effect.” Journal of Finance and Economics, 46(05): 17–36. Wu, Bingxiao. 2019. “Physician Agency in China: Evidence from a Drug-Percentage Incentive Scheme.” Journal of Development Economics, 140: 72–89. Yang, Yu-Chen, Hsing Kenneth Cheng, Chao Ding, and Shengli Li. 2017. “To Join or Not to Join Group Purchasing Organization: A Vendor’s Decision.” European Journal of Operational Research, 258(2): 581–589. Yao, Yu. 2014. “Cost-Control Mechanisms and the Operational Logic of Public Hospitals in China.” Chinese Social Sciences, (12): 60–80. Zaixiang, Tan, and Song Qingqing. 2020. “Legal Risks and Countermeasure Research on the Drug Supply in Public Hospitals Under the Expansion of the 4+7 Volume-Based Procurement Policy.” Chinese Health Service Management, 37(12): 913–915, 931. Zhao, Boya, and Jing Wu. 2023. “Impact of China’s National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin.” International Journal of Health Policy and Management, 12. Zhao, Li, Zhao Ke, Zhou Lyu-lin, and Chen Sheng. 2021. “Comparison and Development Strategy Research of the Procurement Modes of Pharmaceutical Groups from the Normalized Perspective of National Centralized Procurement.” Chinese Journal of Health Policy, 14(11): 61–66. Zhou, Deyu, Liping Kuai, Dongyan Xu, and Lijuan Tian. 2023. “Analysis of the Shortage of Drugs in National Centralized Volume-Based Procurement and Countermeasures and Suggestions.” China Pharmacy, 769–773. |
URI: | https://mpra.ub.uni-muenchen.de/id/eprint/123015 |